ENARA BIO
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from endogenous retroviral (ERV)-related DNA sequences.
ENARA BIO
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enarabio.com
Total Employee:
11+
Status:
Active
Total Funding:
17.5 M USD
Technology used in webpage:
SPF GoDaddy DNS Digital Ocean Mimecast KnowBe4 Smartsheet
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
STipe Therapeutics
STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Series A - Enara Bio
RA Capital Management
RA Capital Management investment in Seed Round - Enara Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-01 | Enara Bio announces the appointment of T-cell therapy leader Dr. Sophie Papa as Chief Medical Officer |
Official Site Inspections
http://www.enarabio.com Semrush global rank: 4.56 M Semrush visits lastest month: 2.29 K
- Host name: 138.68.116.208
- IP address: 138.68.116.208
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Enara Bio"
Enara Bio - LinkedIn
Enara Bio | 7,712 followers on LinkedIn. Advancing cancer immunotherapy by targeting the unconventional | Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer ...See details»
Enara Bio Strengthens Senior Leadership with Key …
Oxford, United Kingdom – May 01, 2025.Enara Bio, a biopharmaceutical company pioneering the development of bispecific T-cell engagers directed against Dark Antigen® and other emerging targets, today announces the …See details»
Enara Bio Strengthens Senior Leadership with Key Executive
2 days ago Stacey Davis appointed as Chief Business Officer and Chief Financial Officer. Clive Wood, Ph.D. joins Enara Board as Non-executive Director. Oxford, United Kingdom – May 01, …See details»
Enara Bio - Crunchbase Company Profile & Funding
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies …See details»
Enara Bio - Overview, News & Similar companies | ZoomInfo.com
View Enara Bio (www.enarabio.com) location in Oxfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Enara Bio - Craft
Enara Bio has 5 employees across 4 locations and $17.5 m in total funding,. See insights on Enara Bio including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
About - Enara Bio
Our name Enara Bio™ is derived from an Arabic word meaning illumination, enlightenment and bringing light into the darkness. We are the leaders in exploring the hidden depths of cancer and T-cell biology to discover and …See details»
Enara Bio - Company Profile & Staff Directory - ContactOut
Enara Bio is a Biotechnology company located in Magdalen Centre, The Oxford Science Park, 1 Robert Robinson Avenue, Oxford, Oxfordshire OX4 4GA, GB with 59 employees. Access …See details»
Research Associate – Cell & Immuno Biology (12 month contract)
Enara Bio’s purpose is to shine a light on unconventional T cell targets to develop cancer immunotherapies designed to provide lasting benefit for broad patient populations.See details»
Enara Bio raises $32.5 million Series B financing to …
Oct 3, 2024 For more information, visit: www.enarabio.com. About Pfizer Ventures. Pfizer Ventures (PV), the venture capital arm of Pfizer Inc., was founded in 2004 and invests for return in areas of current or future strategic …See details»
Enara Bio 2025 Company Profile: Valuation, Funding & Investors
Dec 15, 2017 Enara Bio General Information Description. Developer of medical drug vaccines and other immunotherapies technology designed to treat cancer. The company's technology …See details»
Enara Bio adds further world‐class cell therapy and …
Dec 16, 2020 For more information visit: www.enarabio.com. FOR MORE INFORMATION Enara Bio Limited Kevin Pojasek, CEO Tel: +44(0)1865 618 828 Email: [email protected]. Citigate …See details»
BI & Enara Bio Enter Strategic Collaboration | BI US - Boehringer …
For more information visit: www.enarabio.com. Enara Bio Media Contacts Enara Bio Limited Kevin Pojasek, CEO P: +44(0)1865 504 994 [email protected]. Citigate Dewe Rogerson …See details»
Careers at Enara Bio - Enara Bio
Our name Enara Bio™ is derived from an Arabic word meaning illumination, enlightenment and bringing light into the darkness. We are the leaders in exploring the hidden depths of cancer …See details»
Enara Bio announces the appointment of highly experienced …
Oxford, UK – 28th September 2021. Enara Bio, a biotechnology company advancing novel T-cell receptor (TCR) directed immunotherapies against unconventional, shared, cancer-specific …See details»
Enara Bio Strengthens Senior Leadership with Key Executive
2 days ago Stacey Davis appointed as Chief Business Officer and Chief Financial Officer. Clive Wood, Ph.D. joins Enara Board as Non-executive Director. Oxford, United Kingdom – May 01, …See details»
Enara Bio relocates to The Oxford Science Park’s newest facility to ...
Dec 9, 2020 For more information visit: www.enarabio.com About The Oxford Science Park The Oxford Science Park is owned and managed by Magdalen College, Oxford. Created in 1991, …See details»
Enara Bio embarks on a research collaboration with George …
“We are excited to be collaborating with the Chiappinelli lab, which has world-leading expertise in cancer epigenetics, transposable element regulation, and genomic dark matter,” said Sophie …See details»
Strategic-collaboration-with-EnaraBio | Boehringer Ingelheim
Jan 12, 2021 Ingelheim, Germany and Oxford and London, UK, January 12th, 2021 – Boehringer Ingelheim and Enara Bio, today announced that they have entered into a strategic …See details»
Technology - Enara Bio
Developing therapeutics to improve outcomes for cancer patients. Our proprietary database of tumor-specific antigens is the foundation for a diverse range of product candidates that can be …See details»